Skip to main content
TipRanks
Go Ultimate75% OFF

BioMark Diagnostics (20B) Stock Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

20B Analyst Ratings

There are no analyst ratings in the last 3 months.

20B Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:20B
Price TargetArticle
TipRanks - PerPlexityEUR 0.33hold27.58%UpsideReiterated10/07/26
TipRanks - GoogleEUR 0.33sell24.67%UpsideReiterated10/07/26
TipRanks - AnthropicEUR 0.33sell26.85%UpsideReiterated10/07/26
TipRanks - OpenAIEUR 0.34hold28.06%UpsideReiterated10/07/26
TipRanks - DeepSeekEUR 0.34hold28.06%UpsideUpgraded10/07/26
TipRanks - xAIEUR 0.33hold27.34%UpsideReiterated10/07/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
HELPHelus Pharma
IMUXImmunic
CABACabaletta Bio
MDWDMediwound
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioMark Diagnostics

3 Months
Anthropic Health Care CA
Anthropic Health Care CATipRanks - Anthropic
Success Rate2/3 ratings generated profit
67%
Average Return
-4.73%

Copying Anthropic Health Care CA's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of -4.73% per trade.

1 Year
Anthropic Health Care CA
Anthropic Health Care CATipRanks - Anthropic
Success Rate2/3 ratings generated profit
67%
Average Return
-2.00%

Copying Anthropic Health Care CA's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -2.00% per trade.

2 Years
Anthropic Health Care CA
Anthropic Health Care CATipRanks - Anthropic
Success Rate2/3 ratings generated profit
67%
Average Return
-2.00%

Copying Anthropic Health Care CA's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of -2.00% per trade.

20B Analyst Recommendation Trends

00.511.52Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 20B
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, 20B has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 20B average Analyst price target in the past 3 months is ―.

20B Financial Forecast

EUR -1EUR 6,053EUR 12,107EUR 18,161EUR 24,215Q2 2026Q4 2026Q2 2027
ConsensusEUR 0.00

20B Sales Forecast

Next quarter’s sales forecast for 20B is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 4,352.135. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

20B Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about BioMark Diagnostics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of BioMark Diagnostics?
To buy shares of DE:20B, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.